TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Using Behavioural Science to Target Increased Uptake in Cancer Screening

Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wakefield CCG: "Using Behavioural Science to Target Increased Uptake in Cancer Screening". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Wakefield CCGScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Wakefield CCG
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Wakefield CCG. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Wakefield CCG
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published23 Mar 2021, 22:56 GMT
Last source update23 Mar 2021, 22:56 GMT
Recurring procurementNot published
ClassificationHealth services
OCIDocds-h6vhtk-029e97
What is being bought
West Yorkshire and Harrogate Cancer Alliance and West Yorkshire and Harrogate Health and Care Partnership, would like to utilise a model which has been developed to use behavioral science to target increased cancer uptake and specifically targets populations of inequality. This specific model has been rolled out in another area of the country and has seen increased uptake of cancer screening. The scope will be broadened to include all three screening programmes and cancer prevention indicators i.e. smoking cessation and healthy weight.
What changed
From the official release history
  1. Status changed to complete
    23 Mar 2021, 22:56 GMT
  2. Official notice release published
    23 Mar 2021, 22:56 GMT
  3. Buyer information updated
    23 Mar 2021, 22:56 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Caja will utilise their sustainable model developed with (and successfully used within) South Yorkshire & Bassetlaw Cancer Alliance) to increase cancer screening uptake in West Yorkshire & Harrogate through primary care, starting in Bradford. Their model empowers stakeholders in behavioural science techniques and applies this to promotion of cancer screening uptake, targeting populations of inequality. They have increased cervical screening uptake in active practices in South Yorkshire by at least 25%. The scope in Bradford will be broadened to include all three screening programmes and cancer prevention indicators, such as smoking cessation and healthy weight.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    23 Mar 2021, 22:56 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 23 Mar 2021, 00:00 GMT · £49,800
Commercial outcome and competition
Awards
CAJA Limited
Not published · Not published · active
Contracts
West Yorkshire and Harrogate Cancer Alliance
£49,800 · signed 23 Mar 2021, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS Wakefield CCG

Contracting authority GB-FTS-9884
View buyer profile
  • NHS Wakefield CCG
    buyer

    White Rose House, West parade, Wakefield, UKE45, WF1 1LT
    +44 1484464262
  • CAJA Limited
    supplier

    Newport House, Newport Road, Stafford, UKG24, ST16 1DA
    +44 1782443018
  • Royal Courts of Justice
    reviewBody

    Strand, Holborn, London, WC2A 2LL
    +44 2079476000
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleCaja have already developed many of the materials needed for this project in a neighbouring area (South Yorkshire and Bassetlaw – SY&B), which provides increased value for money in WY&H: mapping the patient’s cancer screening journey for the cervical and breast programmes, a suite of behavioural science interventions to be tested in different practice populations and stakeholder workshop materials to educate staff about how to use behavioural science techniques. This has substantially reduced costs and allowed Caja to include the bowel screening programme in addition to prevention indicators, namely smoking cessation and healthy weight. This also speeds up the timeline of the project, and the proposed plan from Caja states the Bradford suite of interventions can be tested and ready by May 2021 with provisional results by June. Cancer Alliance modelling has shown that there are hundreds of ‘missed’ cancers in its region due to the COVID pandemic, some of which will be asymptomatic and could be diagnosed via screening; the Alliance must act quickly to find them and improve people’s chances of survival. As their SY&B project is currently underway, Caja will be using the live learning from this in WY&H as the project progresses. For example, the practices that have ‘gone live’ in SY&B have highly socio-economically deprived practice populations. The WY&H practices selected for the first pilots have similar practice populations and so the model and interventions used will be very similar (but will be tested locally to ensure they are as effective). The next SY&B practices to go live have high proportions of ethnic minorities in their practice populations, and the learning from this will be used to inform the expansion of the Bradford project into practices serving ethnic minorities who have lower screening uptake. Caja’s model involves the education of regional and primary care staff around behavioural science and its applications, providing crucial sustainability compared to ‘parachute projects’ where additional staff are acquired temporarily. The empowerment of the existing workforce means that these techniques can be employed beyond the timeline of this project and applied wider than cancer screening and prevention. The Alliance are already hearing examples from SY&B of where else they have used the techniques which have been learnt. As we emerge from the pandemic, we can no longer ignore health inequalities and this project will help us to reduce those inequalities related to cancer, whilst supporting screening programme restoration as per the NHS Phase 3 letter. In SY&B cervical screening uptake has increased in ‘live’ practices by at least 25%, which, if replicated in Bradford for all three programmes has the potential to reduce health inequalities by saving many lives through prevention and early diagnosis of cancer.